$13.95
1.71% day before yesterday
Nasdaq, Nov 01, 08:15 pm CET
ISIN
SG9999014716
Symbol
WVE
Sector
Industry

Wave Life Sciences Ltd. Target price 2024 - Analyst rating & recommendation

Wave Life Sciences Ltd. Classifications & Recommendation:

Buy
90%
Hold
10%

Wave Life Sciences Ltd. Price Target

Target Price $19.50
Price $13.83
Potential
Number of Estimates 10
10 Analysts have issued a price target Wave Life Sciences Ltd. 2025 . The average Wave Life Sciences Ltd. target price is $19.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 9 Analysts recommend Wave Life Sciences Ltd. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Wave Life Sciences Ltd. stock has an average upside potential 2025 of . Most analysts recommend the Wave Life Sciences Ltd. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 113.31 69.13
3,004.38% 38.99%
EBITDA Margin -51.88% -215.52%
98.76% 315.39%
Net Margin -58.37% -170.08%
99.15% 191.38%

10 Analysts have issued a sales forecast Wave Life Sciences Ltd. 2024 . The average Wave Life Sciences Ltd. sales estimate is

$69.1m
Unlock
. This is
37.44% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$122m 10.41%
Unlock
, the lowest is
$35.8m 67.60%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $113m 3,004.38%
2024
$69.1m 38.99%
Unlock
2025
$66.0m 4.47%
Unlock
2026
$99.0m 49.91%
Unlock
2027
$230m 132.53%
Unlock
2028
$367m 59.40%
Unlock

1 Analyst has issued an EBITDA forecast Wave Life Sciences Ltd. 2024 . The average Wave Life Sciences Ltd. EBITDA estimate is

$-149m
Unlock
. This is
98.93% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-149m 98.93%
Unlock
, the lowest is
$-149m 98.93%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-58.8m 61.48%
2024
$-149m 153.44%
Unlock
2025
$-182m 22.15%
Unlock
2026
$-216m 18.68%
Unlock

EBITDA Margin

2023 -51.88% 98.76%
2024
-215.52% 315.39%
Unlock
2025
-275.58% 27.87%
Unlock
2026
-218.16% 20.84%
Unlock

4 Wave Life Sciences Ltd. Analysts have issued a net profit forecast 2024. The average Wave Life Sciences Ltd. net profit estimate is

$-118m
Unlock
. This is
65.52% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-107m 50.00%
Unlock
, the lowest is
$-125m 75.86%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-66.1m 73.66%
2024
$-118m 77.78%
Unlock
2025
$-141m 19.79%
Unlock
2026
$-132m 6.52%
Unlock
2027
$-98.6m 25.12%
Unlock
2028
$-80.2m 18.64%
Unlock

Net Margin

2023 -58.37% 99.15%
2024
-170.08% 191.38%
Unlock
2025
-213.27% 25.39%
Unlock
2026
-132.99% 37.64%
Unlock
2027
-42.83% 67.79%
Unlock
2028
-21.86% 48.96%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.54 -0.96
73.66% 77.78%
P/E negative
EV/Sales 29.30

4 Analysts have issued a Wave Life Sciences Ltd. forecast for earnings per share. The average Wave Life Sciences Ltd. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.96
Unlock
. This is
65.52% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.87 50.00%
Unlock
, the lowest is
$-1.02 75.86%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.54 73.66%
2024
$-0.96 77.78%
Unlock
2025
$-1.15 19.79%
Unlock
2026
$-1.08 6.09%
Unlock
2027
$-0.81 25.00%
Unlock
2028
$-0.66 18.52%
Unlock

P/E ratio

Current -23.80 504.06%
2024
-14.41 39.45%
Unlock
2025
-12.03 16.52%
Unlock
2026
-12.86 6.90%
Unlock
2027
-17.18 33.59%
Unlock
2028
-21.11 22.88%
Unlock

Based on analysts' sales estimates for 2024, the Wave Life Sciences Ltd. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

29.30
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
30.99
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 18.33 68.94%
2024
29.30 59.83%
Unlock
2025
30.67 4.68%
Unlock
2026
20.46 33.29%
Unlock
2027
8.80 57.00%
Unlock
2028
5.52 37.27%
Unlock

P/S ratio

Current 19.39 34.62%
2024
30.99 59.84%
Unlock
2025
32.44 4.68%
Unlock
2026
21.64 33.29%
Unlock
2027
9.31 57.00%
Unlock
2028
5.84 37.27%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today